Stem cell, an undifferentiated cell that can split to generate certain descendants cells that remain as stem cells and some cells that are (become specific) supposed to distinguish. Stem cells are a continuous cause of differentiated cells that create up animal and plant tissues and organs (Slack, 2018). Stem cells are of excellent concern because they have the ability to develop therapies to replace faulty or harmed cells caused by a multitude of illnesses and accidents, such as Parkinson’s disease, heart disease, and diabetes (ibid). Because pluripotent stem cells can distinguish into any sort of cell, they are used for a broad spectrum of circumstances in the creation of medical procedures (Mahla, 2016). Treatments suggested include (in conjunction with cell therapy) treatment for physical trauma, degenerative conditions and genetic diseases. However, owing to their capacity to cure comprehensive tissue harm, additional therapy using stem cells could be created (Cossu et al, 2018). This essay will discuss the stem cell, identify its types, discuss wellness hazards and their advantages for the e environment, and verify that stem cell research will assist and contribute to higher progress in health care.
There are two types of stem cells that are still being researched because some researchers believe that study into stem cells will contribute to higher progress in wellness regulations. When most individuals believe about disease treatment stem cells, they believe of a transplant of stem cells. Embryonic stem neurons are first specialised in the required sort of mature cell in a stem cell transplant. These mature cells then substitute tissue harmed by illness or accident. You could use this sort of therapy to Replace neurons harmed by spinal cord trauma, stroke, Alzheimer’s illness, Parkinson’s illness or other neurological issues; generate glucose that can help individuals with asthma and blood muscle cells that can fix cardiac assault harm; or nearly substitute any wounded or diseased tissue or organ (Lindvall, 2004). First of all, There are many types of stem cells and it depends on the remedies they come from, such as adult stem cells found in adult tissue, embryonic stem cells derived from early embryos, cord blood stem cells found in umbilical cord blood and induced pluripotent stem cells (IPS cells) these cells were ‘ reprogrammed ‘ from body cells to behave like embryonic stem cells. Stem cells may be used as a treatment source for diseases of the central nervous system. Although it has long been thought that mammalian neurogenesis occurs only in embryonic and perinatal stages, as Altman and Das demonstrated in the early 1960s, young neurons are continuously incorporated into the adult brain (Altman, 1962; Altman and Das, 1965).Indeed, neural stem cells (NSCs), which reside in the brain of most human mammals in the so-called ‘neurogenic niches,’ support life-long neurogenesis. The neuropoietic niche in an adult human hippocampus is estimated to generate 700 new neurons each day, outlining one aspect of NSC plasticity / renewal capacity (Knoth et al., 2010; Spalding et al., 2013). As for other stem cells, the neurogenic niche’s specific microenvironment guarantees not only self-renewal of NSC, but also differentiation into neurons in particular (Ottoboni, 2017).
There are more new researches about stem cell and how it can benefit the human body. For instance, stem cells are strong experimental instruments to screen big numbers of sample samples with high-throughput results. Miniaturization increases the assay throughput while reducing the consumption of reagents and the number of cells required, making these systems attractive for a wide range of drug discovery, toxicology, stem cell research and potentially therapy assays. An overview has been provided of evolving techniques that can be used to produce cellular microarrays, important developments have been highlighted in the sector recently. This evolving and multidisciplinary strategy provides fresh possibilities for tissue engineering and cellular therapy design and control of stem cells and promises to accelerate the discovery of drugs in the biotechnology and pharmaceutical industries (Fernandes, 2009). Recent advances in embryo Stem Cell’s clinical implementation render them a significant target for the use of stem cells alongside Mature Stem Cell and IPS (Golchin et al, 2017). However, owing to its significance in many ways, further research are required (ibid). Another aspect of stem cell advantages is that cardio myocytes derived from human pluripotent stem cells have phenotype modelling benefits, culture longevity, transfection convenience, and high-throughput capacity (Harding and Sian, 2011).
If each stem cell type is taken individually, each cell type will have its own work or guest that benefits the human body or the animal. For instance, the stem cells of the marrow have many of the features of tissue stem cells that can be approximately described as mesenchymal because they can be distinguished into osteoblasts, chondrocytes, adipocytes and even myoblasts in culture (Prockop, 1997). Marrow stromal cells therefore pose an interesting model to examine stem cell differentiation. They also have several features that render them possibly beneficial for cell and gene treatment (ibid). Spinal cord injury (SCI) leads to main and secondary neural tissue harm, which often leads to continuous engine and sensory disability. Since the discovery of stem cells, regenerative medicine has developed remarkably, and many studies have suggested the potential of cell-based neural injury therapy. In particular, in vitro and vivo designs were used to demonstrate the medicinal ability of human umbilical cell vessels (hUCB proteins) for intractable neurological disorders. The hUCB cells are immune naïve and can distinguish themselves from other phenotypes, including the genetic pathway. Also observed was their capacity to generate multiple neurotropic variables and to modulate immune and inflammatory responses (Park et al, 2011). A specified and renewable source of animal cells appropriate for cell substitute therapies and toxicology research could be hepatocytes obtained from animal embryonic stem proteins (hESCs) or engineered pluripotent stem cells (iPSCs) (Jozefczuk et al, 2010).
Although the stem cell researchers believe that stem cells will lead to a great evolution in the science and treatment of chronic diseases, some of them think that while using stem cells there is some risk that could be faced and some will be summarized. Hematopoietic stem tissue transplantation (HSCT) has been used to heal a range of malignant and non-malignant illnesses since it was first implemented almost 40 years earlier. While this modality can be a life-saving therapy for many people, the cytotoxic regimens and the growth of GVHD often lead to important morbidity. Toxicity of the gastrointestinal tract’s quickly dividing cells manifests as serious mucositis and enteritis causing painful verbal ulcerations (Arfons and Lazarus, 2005). Although cancer can be handled purchase stem cell. But this treatment is technologically complicated, needing high-dose chemotherapy to eradicate malignant cells, sometimes in combination with radiation therapy. In the process, healthy precursor cells of the bone marrow are destroyed and replaced by the patient’s own cells (autologous transplantation) (Mitchel and Conklin, 2015). There is a problem which has caused some individuals to reject stem cells and this has contributed to a decrease in education or stem cell research in some nations has become illegal, but at the same moment it is a private view and not because of the stem cells themselves. And those individuals believe that when human embryos are acquired from pre-implantation stem cells, ethical concerns emerge from the need to kill embryos in order to acquire them. Those who think that human embryos preimplantation are themselves individuals or objects with freedoms are opposed to the demolition of embryos for studies, while those who consider the embryo to be too rudimentary in growth to have an intrinsic social position usually allow this study (Robertson, 2001).
Moreover, a greedy person may lead to the use of human beings as means of commerce. For example, Researchers are increasingly looking for young women’s eggs to be used for embryo cloning and stem cell researches. Multiple egg harvesting often includes administering drugs that have not been approved for this purpose. These drugs have also not been properly researched for their long-term impacts on females despite some proof of important short- and long-term damage to females. Current procedures follow a historic pattern of exposing females to potentially unacceptable hazards. Furthermore, egg harvesting takes place in a climate of studies marked by conflicts of interest, the inaccurate use of stem cells to describe study objectives, and a commercial push that could lead to the exploitation of young females (Beeson and Lippman, 2006)
Finally, Stem cell technology is unique because it has the potential for both diagnosis and therapies. IPS cells and their derivatives supplied great disease process models in vitro. For drug discovery and toxicology research, patient-specific IPS cell models will also serve as an invaluable instrument. These cells ‘ therapeutic potential for functional tissue regeneration and replacement of damaged tissue has huge potential. In addition, stem cell-based therapies can improve the capacity of the body to repair itself. Nonetheless, significant barriers stay and must be resolved systematically in order to implement these therapies securely. The most immediate among these is the identification of populations of stem cells that can be sustained and extended in cultivation to provide the big numbers required for therapeutic use. The potential for cancer conversion and immunological dismissal is also mainly unexplored (Leventhal, 2012). Although using stem cells at a high price, it is not as important as the importance of a person’s life, because this high price will buy your life and the other disadvantages that doctors and scientists do not properly transplant stem cells, so you cannot blame stem cells for personal mistake. From all of that it is obvious that the developing in stem cell researches will benefit the health development and will save many lives.
- Altman, J., 1962. Are new neurons formed in the brains of adult mammals?. Science, 135(3509), pp.1127-1128. https://science.sciencemag.org/content/135/3509/1127
- Altman, J.O.S.E.P.H. and Das, G.D., 1965. Post-natal origin of microneurones in the rat brain. Nature, 207(5000), pp.953-956. https://www.semanticscholar.org/paper/Post-Natal-Origin-of-Microneurones-in-the-Rat-Brain-Altman-Das/0fdaf6edefe310f0b220f8400b6726bcccc2f6e6
- Arfons, L.M. and Lazarus, H.M., 2005. Total parenteral nutrition and hematopoietic stem cell transplantation: an expensive placebo?. Bone marrow transplantation, 36(4), p.281. https://www.nature.com/articles/1705039
- Beeson, D. and Lippman, A., 2006. Egg harvesting for stem cell research: medical risks and ethical problems. Reproductive biomedicine online, 13(4), pp.573-579. https://www.sciencedirect.com/science/article/pii/S1472648310606475
- Cossu, Birchall, Brown, De Coppi, Culme-Seymour, Gibbon, Hitchcock, Mason, Montgomery, Morris, Muntoni, Napier, Owji, Prasad, Round, Saprai, Stilgoe, Thrasher, and Wilson. ‘Lancet Commission: Stem Cells and Regenerative Medicine.’ The Lancet 391.10123 (2018): 883-910. Web. https://www.sciencedirect.com/science/article/pii/S0140673617313661
- Fernandes, T.G., Diogo, M.M., Clark, D.S., Dordick, J.S. and Cabral, J.M., 2009. High-throughput cellular microarray platforms: applications in drug discovery, toxicology and stem cell research. Trends in biotechnology, 27(6), pp.342-349. https://www.sciencedirect.com/science/article/abs/pii/S0167779909000705
- Golchin, Ali, and Hasan Niknejad. ‘Cell Therapy Using Embryonic Stem Cell Source in Clinical Trial Studies: Advantages and Limitations.’ Journal of Mazandaran University of Medical Sciences 27.148 (2017): 166-80. Web. http://jmums.mazums.ac.ir/article-1-9960-en.html
- Harding, Sian E. ‘Human Stem Cell‐derived Cardiomyocytes for Pharmacological and Toxicological Modeling.’ Annals of the New York Academy of Sciences 12451.1 (2011): 48-49. Web. https://nyaspubs.onlinelibrary.wiley.com/doi/full/10.1111/j.1749-6632.2011.06328.x
- Jozefczuk, J., Prigione, A., Chavez, L. and Adjaye, J., 2010. Comparative analysis of human embryonic stem cell and induced pluripotent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation. Stem cells and development, 20(7), pp.1259-1275. https://www.liebertpub.com/doi/abs/10.1089/scd.2010.0361
- Knoth, R., Singec, I., Ditter, M., Pantazis, G., Capetian, P., Meyer, R.P., Horvat, V., Volk, B. and Kempermann, G., 2010. Murine features of neurogenesis in the human hippocampus across the lifespan from 0 to 100 years. PloS one, 5(1), p.e8809. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008809
- Leventhal, A., Chen, G., Negro, A. and Boehm, M., 2012. The benefits and risks of stem cell technology. Oral diseases, 18(3), p.217. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752464/
- Lindvall, O., Kokaia, Z. and Martinez-Serrano, A., 2004. Stem cell therapy for human neurodegenerative disorders–how to make it work. Nature medicine, 10(7s), p.S42. https://www.nature.com/articles/nm1064
- Mahla, R.S., 2016. Stem cells applications in regenerative medicine and disease therapeutics. International journal of cell biology, 2016. https://www.hindawi.com/journals/ijcb/2016/6940283/abs/
- Mitchell, J.M. and Conklin, E.A., 2015. Factors affecting receipt of expensive cancer treatments and mortality: evidence from stem cell transplantation for leukemia and lymphoma. Health services research, 50(1), pp.197-216. https://onlinelibrary.wiley.com/doi/full/10.1111/1475-6773.12208
- Ottoboni, Linda, Arianna Merlini, and Gianvito Martino. ‘Neural Stem Cell Plasticity: Advantages in Therapy for the Injured Central Nervous System.’ Frontiers In Cell And Developmental Biology 5.MAY (2017): 52. Web. https://www.frontiersin.org/articles/10.3389/fcell.2017.00052/full
- Park, Dong-Hyuk, Jeong-Hyun Lee, Cesario V. Borlongan, Paul R. Sanberg, Yong-Gu Chung, and Tai-Hyoung Cho. ‘Transplantation of Umbilical Cord Blood Stem Cells for Treating Spinal Cord Injury.’ Stem Cell Reviews And Reports 7.1 (2011): 181-94. Web. https://link.springer.com/article/10.1007/s12015-010-9163-0
- Prockop, D.J., 1997. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science, 276(5309), pp.71-74. https://science.sciencemag.org/content/276/5309/71
- Robertson, J.A., 2001. Human embryonic stem cell research: ethical and legal issues. Nature Reviews Genetics, 2(1), p.74. https://www.nature.com/articles/35047594
- Slack, J.M., 2018. The Science of Stem Cells. John Wiley & Sons. https://books.google.co.uk/books?hl=en&lr=&id=1g5MDwAAQBAJ&oi=fnd&pg=PR11&dq=Jonathan+M.W.+Slack+stem+cells&ots=NSMcvYMW5a&sig=gDG6z3Se0bt95aPav9e92h1pBWY#v=onepage&q=Jonathan%20M.W.%20Slack%20stem%20cells&f=false
- Spalding, K.L., Bergmann, O., Alkass, K., Bernard, S., Salehpour, M., Huttner, H.B., Boström, E., Westerlund, I., Vial, C., Buchholz, B.A. and Possnert, G., 2013. Dynamics of hippocampal neurogenesis in adult humans. Cell, 153(6), pp.1219-1227. https://www.sciencedirect.com/science/article/pii/S0092867413005333